Jasper Therapeutics, Inc. JSPR
0.48 USD -0.03 (-5.51%)
At closeNov 3, 2026, 4:00 PM EST
0.51 +0.03 +7.02%
After hours · Nov 3, 4:00 PM ET
0.47 Day range 0.5299
0.315 52-week range 2.42
- YTD
- -73.77%
- 1 year
- -77.14%
Financial health
Altman Z-Score
-45.58 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E -0.5×
FY 2019 5y median -1.3× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 8.5×
FY 2019 5y median 1.3× FY 2025
P/FCF -0.5×
FY 2019 5y median -1.6× FY 2025
EV/EBITDA -0.1×
FY 2019 5y median -0.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -220.0%
FY 2019 5y median -63.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -1826.1%
FY 2019 5y median -104.7% FY 2025
ROIC -338.1%
FY 2019 5y median -116.0% FY 2025
ROA -211.9%
FY 2019 5y median -77.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -5.6%
FY 2019 FY 2025
EPS (diluted) 19.2%
FY 2019 FY 2025
Free Cash Flow -22.2%
FY 2019 FY 2025
Financial Health
Current Ratio 2.6×
FY 2019 5y median 5.9× FY 2025
Quick Ratio 2.6×
FY 2019 5y median 5.9× FY 2025
Debt / Equity 0.3×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2019 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31